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MAP kinase signalingThe tissuemicromilieu in disorders (inﬂammation, ischemia, tumor) often shows pronouncedmetabolic acidosis
that may alter signaling and transcriptional activity in resident cells which can be of special importance for
omnipresent ﬁbroblasts. In the present study we investigated the impact of metabolic acidosis on rat ﬁbroblasts
with special emphasis on their role in inﬂammation by regulation of TNF-α, MCP-1, COX-2 and iNOS expression
and the signaling pathways involved.
Extracellular acidosis led to an enhanced expression of TNF-α, COX-2 and iNOS in parallel to an activation of
p38 and ERK1/2 kinases that was not observed by sole intracellular acidosis. Accordingly, the protein amounts
of TNF-α and COX-2 as well as the production of nitrate and nitrite were elevated. Acidosis-induced expression
of COX-2 and iNOS depended on p38 kinase, but not on ERK1/2. In contrast acidosis-induced TNF-α expressionwas
independent of both kinases. Although GPR4, GPR68 and GPR132 are expressed in ﬁbroblasts, the involvement of
these potential candidate pH sensors could be ruled out since no acidosis-induced elevation in intracellular cAMP
or free calcium content was observed. Furthermore our data show that MAPK activation by an acidic micromilieu
depends on Ser/Thr phosphatase activity, but not on the production of reactive oxygen species and is sensitive to
cAMP antagonism by Rp-cAMPS. In conclusion, our results show that an acidic microenvironment induces a
differential transcriptional program of pathological relevant genes in ﬁbroblasts via the cAMP-phosphatase–
MAPK pathway and thereby generates a parainﬂammatory situation that can result in tissue remodeling.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Under different pathological conditions like inﬂammation, ischemia
or in solid tumors, physiological parameters such as local oxygenation
or extracellular pH show distinct abnormalities (e.g., hypoxia, acidosis)
in the tissue. These factors may impair cell function and phenotype and
in turn aggravate the pathological process. The development of extra-
cellular acidosis is the result of the production and release of acids by
the cells or a hampered removal of CO2 [1]. Extracellular acidosis acts
on all cells of the affected tissue and may therefore lead to different
cellular responses, resulting in the activation of distinct pathophysiological
processes. It modulates the inﬂammatory response in neutrophils,
eosinophils, monocytes, macrophages, dendritic and endothelial cells
as well as platelets [2–7]. However, the impact of acidosis on ﬁbroblasts
is presently not fully understood. For this reason the present study
addresses the question of howmetabolic acidosis affects the expression
of different inﬂammatory mediators (TNF-α, COX-2, MCP-1 and iNOS)
in ubiquitous tissue ﬁbroblasts. TNF-α is one of the most importantt für Physiologie, Universität
aale), Germany. Tel.: +49 345
A. Riemann).pro-inﬂammatory cytokines [8–12] and has been linked to tumorigenesis
including cellular transformation, proliferation, survival, angiogenesis,
invasion and metastasis [13,14]. COX-2 and iNOS exacerbate inﬂamma-
tion by elevated production of reactive prostaglandins and nitrogen
species, respectively [15–18]. In cancer, nitric oxide (NO) has an
ambiguous role and its effect on tumor development depends on its
concentration and the cellular content [19]. For instance, NO can either
lead to the induction of genotoxic lesions [20] or reduce DNA oxidation
by reactive oxygen species [21]. COX-2 is not detectable under normal
conditions in most cells, but is highly up-regulated under conditions
of inﬂammation. Additionally, it is over-expressed in cancer as well as
stromal cells and is involved in angiogenesis, invasiveness as well as
resistance to apoptosis [22–24]. Besides, COX-2 inhibitors reduce the
risk of several cancers [25]. MCP-1 is involved in the recruitment and
activation of leukocytes as well as the immunity of T-cells [26]. It is
linked to inﬂammation [27], ischemia [28] and cancer where it can
increase macrophage inﬁltration and macrophage-mediated angiogene-
sis, but also stimulate the host antitumor response [26,29].
The essential role of ﬁbroblast in different diseases ismore andmore
appreciated. Cancer-associated ﬁbroblasts (CAFs) are involved in both
tumor initiation and progression [30,31]. They support primary tumor
growth through growth-promoting factors and contribute to cancer
cell invasiveness through remodeling of extracellular matrix, cell–cell-
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ﬁbroblasts govern the persistence of inﬂammation by facilitating the
accumulation, survival and retention of immune cells within the site of
inﬂammation [33,34]. The question arises by which signaling pathway
the acidic tissue environment affects gene expression. In tumor cells it
has been shown that extracellular acidosis activates MAPK (mitogen-ac-
tivated protein kinases) ERK1/2 and p38 [35]. However, it is unclear
whether these pathways are also involved in normal tissues. Therefore,
the effects of acidosis on ERK1/2 and p38 activities as well as the
consequences of this activation on gene expression were studied in rat
ﬁbroblasts (NRKF). In addition, signaling steps upstream the MAPK as
well as the role of the intracellular pH for pH sensing were analyzed.
2. Materials and methods
2.1. Cell culture
Normal rat kidney ﬁbroblasts (NRK-49F, ATCC CRL-1570) were
grown in DMEM medium supplemented with 5% fetal calf serum (FCS)
and 1.5 g/l of NaHCO3 at 37 °C under a humidiﬁed 5% CO2 atmosphere
and sub-cultivated once perweekbefore conﬂuency. For all experiments,
cells were grown in Petri dishes (isolation of RNA or protein) or cover
slips (measurement of pHi or [Ca2+]i). To exclude negative effects of
acidic treatment on cell viability LDH release to monitor necrosis and
caspase-3 activity as indicator for apoptosis was analyzed accordingly
[36]. Incubation periods up to 24 h did not induce necrotic or apoptotic
cell death.
2.2. Experimental setup
The cells were transferred to medium without additional FCS
supplementation for 24 h and afterwards incubated for up to 6 h in
Ringer's solutions. Control cells were exposed to bicarbonate HEPES-
buffered Ringer's solution adjusted to pH 7.4 (NaHCO3 24.0 mM,
Na2HPO4 0.8 mM, NaH2PO4 0.2 mM, NaCl 86.5 mM, KCl 5.4 mM, CaCl2
1.2 mM, MgCl2 0.8 mM, HEPES 20 mM; pH adjustment with 1 N of
NaOH). Extracellular acidosis (pH 6.6) was applied using isoosmotic
bicarbonate MES-buffered Ringer's solution (NaHCO3 4.5 mM,
Na2HPO4 0.8 mM, NaH2PO4 0.2 mM, NaCl 106.0 mM, KCl 5.4 mM,
CaCl2 1.2 mM, MgCl2 0.8 mM, MES (morpholinoethanesulfonic acid)
20 mM; pH adjustment to 6.6 with 1 N of NaOH). The buffer capacity
(β) is 5.9 mM× ΔpH for the bicarbonate HEPES-buffered Ringer's solu-
tion at pH 7.4 and 3.9 mM × ΔpH for the bicarbonate MES-buffered
Ringer's solution. All inhibitors or activators used were added during
this incubation period. For intracellular acidosis 40 mM of NaCl was
replaced by 40 mM of propionic acid (pH 7.4). For incubation periods
longer than 6 h DMEMmedium with 1.5 g/l of NaHCO3 was used and
adjusted to pH 7.4 or pH 6.6 with 1 M of HCl. Extracellular pH (pHe)
wasmeasuredwith a blood gas analyzer (ABL5, Radiometer, Copenhagen,
Denmark). Only aminor reduction in pHe of Ringer's solutions andDMEM
medium was observed during the chosen incubation periods. Therefore
the experiments could be performed under well controlled conditions.
2.3. Determination of cytosolic pH and intracellular calcium
Cytosolic pH (pHi) and free cytosolic calcium ([Ca2+]i) of single
cells were determined using the pH-sensitive dye BCECF (2′,7′-bis-
(2-carboxyethyl)-5-(and-6)-carboxyﬂuorescein, acetoxymethyl ester,
Invitrogen, Paisley, UK) or Ca2+-sensitive dye Fura-2/AM (Merck,
Darmstadt, Germany) as described before [37–39]. In brief, cells were
incubated with Ringer's solution containing 5 μM of BCECF-AM or
5 μM of Fura-2/AM for 15 min. Then, the cover slips were rinsed 2
times with superfusion solution to remove the excess of the dye and
transferred to the stage of an inverted Axiovert 100 TV microscope
(Zeiss, Oberkochen, Germany). Excitation light source was a 100 W
mercury lamp. The excitation wavelengths were 450 nm/490 nm forpHi and 340 nm/380 nm for [Ca2+]i measurement, the emitted
light was ﬁltered through a bandpass-ﬁlter (515–565 nm). The data
acquisition rate was one ﬂuorescence intensity ratio every 10 s or 5 s,
respectively. After background subtraction, ﬂuorescence intensity ratios
were calculated. pH calibration was performed after each experiment by
the nigericin (Sigma, St. Louis, USA) technique [40,41] using a two-point
calibration (pH 6.8 and 7.5). The calibration solutions contained
132 mM of KCl and 1 mM of CaCl2, 1 mM of MgCl2, 10 mM of HEPES
and 10 μM of nigericin. Calibration for [Ca2+]i was performed using a
two-point calibration (1mMof CaCl2 and 1mMof EGTA). The calibration
solutions contained141mMofNaCl, 4mMofKCl, 1mMofMgCl2, 3.2mM
of Na2HPO4, 0.8 mM of NaH2PO4 and 1 μM of ionomycin. Concentrations
of [Ca2+]i were calculated according to the formula described in [39].
2.4. Nitrate/nitrite ﬂuorometric assay
The total formation of NO was determined by nitrate/nitrite assay kit
(Cayman, Ann Arbor, MI, USA). First nitrate is converted by nitrate reduc-
tase tonitrite,which reacts in a second stepwith 2,3-diaminonaphthalene
giving a ﬂuorescent product. 20 μl of cell supernatant (Ringer's solution)
was collected after 3 h or 6 h incubation at pH 7.4 or pH 6.6 and nitrate
and nitrite determined according to the manufacturer's instruction.
Fluorescence was measured at an excitation wavelength of 365 nm
and an emission wavelength of 430 nm using a multiwell counter
(Inﬁnite, Tecan, Berlin, Germany).
2.5. ROS formation
Formation of reactive oxygen species (ROS) was assessed with the
ﬂuorescent dye DCFDA-AM (Molecular Probes, Leiden, Netherlands)
which reacts with an increase in ﬂuorescence in the presence of H2O2
once the ester bond has been cleaved by cellular esterases. Cells were
seeded in 24-well-plates and incubated for up to 3 h with dye and the
indicated treatments. Subsequently, ﬂuorescence (excitation 485 nm;
emission 535nm)wasmeasured in cell lysates using amultiwell counter
(Inﬁnite, Tecan, Berlin, Germany). Additionally blank values without
cells and blank values without dye were determined and subtracted.
The increase of ﬂuorescence over the blank value expressed per mg
protein was used as a measure for ROS formation.
2.6. Determination of cAMP
Changes in the level of cAMPwere quantiﬁed using the screen quest™
cAMP colorimetric ELISA assay kit (Biomol, Hamburg, Germany).
The assay was performed in a 96-well microplate format with
100.000 cells/well according to the manufacturer's instruction. Absor-
bance was monitored at 405 nm and 740 nm using a multiwell counter
(Inﬁnite, Tecan, Berlin, Germany).
2.7. Western blot
Western blotting was performed according to standard protocols.
Cells were lysed (0.5 M of Tris–HCl pH 6.8; 10% SDS; 10% 2-
Mercaptoethanol; 20% Glycerol; 0.01% Bromphenolblue), separated
by SDS-PAGE and transferred to a nitrocellulose membrane. Subsequent-
ly, membranes were incubated with antibodies speciﬁc for ERK1/2, p38,
phospho-ERK1/2 and phospho-p38 (Cell Signaling), COX-2 (ab52237,
Abcam), membrane-bound form of TNFα (ab66579, Abcam). The bound
primary antibody was visualized using horseradish peroxidase (HRP)-
conjugated secondary antibodies and Serva chemiluminescence reagent
for HRP (Serva) with the Molecular Imager ChemiDoc XRS System
(Biorad, Munich, Germany). Quantitative analysis was performed with
Quantity One software (Biorad, Munich, Germany). Phosphorylated
ERK1/2 andp38was normalized against total ERK1/2 or p38, respectively,
while COX-2 and TNFαwere normalized againstβ-actin (rabbitmAB, Cell
Signaling).
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Total RNAwas isolated fromNRKF cells using the InviTrap Spin Tissue
RNAMini kit (Invitek). 1 μg of RNAwas subjected to reverse transcription
with SuperScript II reverse transcriptase (Invitrogen, Carlsbad, CA, USA)
and analyzed by qPCR using the Platinum SYBR Green qPCR Supermix
(Invitrogen, Carlsbad, CA, USA); each step according to themanufacturer's
instructions. The obtained data was normalized against Rn18S. The
following primers were used:Target Forward primer Reverse primerTnf-α CCACCACGCTCTTCTGTCTACTGAACT CCATTGGCCAGGAGGGCGTT
Ccl2/Mcp-1 CCCAGAAACCAGCCAACT TGCTGCTGGTGATTCTCTTG
Nos2/iNos GCAGGTTGAGGATTACTTCTTCCA GCCCTTTTTTGCTCCATAGGAAA
Ptgs2/Cox2 TACAAGCAGTGGCAAAGGCC CAGTATTGAGGAGAACAGATGGG
Gpr4 GCTGTGGGTCGACTACTTCC CTCGAAGCAGAAGGTGTGGT
Gpr65 TTTCCACGTGATGGTGCTCA TCGGGATCTATTGCGCTTCC
Gpr68 TAT CTC CAT CGA CCG CTA CC TCG TCT TCG ATG ACC TCC TT
Gpr132 AGAACCCACCAATGCAACAG CAGAACAGGTAGACGGCGAG
Rn18s CTG AGA AAC GGC TAC CAC ATC CCC AAG ATC CAA CTA CGA GC2.9. Materials
If not stated otherwise, chemicals were purchased from Sigma-
Aldrich, Munich, Germany.
2.10. Data analysis
Data are presented as mean ± SEM. For all other experiments, n
equals the total number of experiments andN thenumber of cell passages
used. All experiments were performed with at least three different
passages. Statistical signiﬁcance was determined by unpaired Student's
t-test or ANOVA, as appropriate. Differences were considered statistically
signiﬁcant when p b 0.05.
3. Results
3.1. Acidosis-induced changes in gene expression
Acidosis-induced expression of IL-1β, IL-6, TNF-α, COX-2, iNOS and
MCP-1/CCL2, which are all relevant for inﬂammatory processes in
different pathological conditions, was analyzed. The pH value of 6.6
used in this study reﬂects the interstitial tissue pH found in inﬂammatory
disease (pH 6.0–7.0) [2] or in solid tumors (pH 6.5–6.8) [42]. IL-1β and
IL-6 were not detectable under the experimental conditions. TNF-α
expression was increased transiently when cells were incubated at
pH 6.6 (Fig. 1A). This increase was detected after 3 h and returned to
control values after 6 h. After 24 h in acidic media a weak decrease of
TNF-α expression was observed. MCP-1 expression was inhibited by
acidosis (Fig. 1B), whereas the expression of iNOS and COX-2 increased
transiently for at least 6 h (Fig. 1C, D). Enhanced expression of iNOS at
pH 6.6 was conﬁrmed by a 1.8 or 2.9 fold increase in nitrite and nitrate
formation in NRKF cells after 3 or 6 h, respectively (Fig. 2C). Additionally,
protein expression of TNF-αwas elevated after 3 h and of COX-2 after 6 h
of acidosis (Fig. 2A, B) whichmore or less directly reﬂect the changes
on mRNA level. These results conﬁrm that an acidotic extracellular
environment activates the expression of inﬂammatory cytokines in
tissue ﬁbroblasts.
3.2. Acidosis activates ERK1/2 and p38
In tumor cells acidosis led to a distinct increase in the phosphorylation
of ERK1/2 and p38 [35]. In rat ﬁbroblasts acidosis led to an elevated
phosphorylation of ERK1/2 and p38 after 3 h while overall proteinamount remained unchanged (Fig. 3A). The time course of MAPK activa-
tion revealed that p38 phosphorylation rose faster (within 10 min) than
ERK1/2 (Fig. 3B; Suppl. Fig. 1). However, within 6 h of acidosis enhanced
phosphorylation returned to control values.
3.3. Impact of MAPK activity on gene expression
To elucidate the role of the MAPK in overall and acidosis-induced
expression of inﬂammatory mediators in ﬁbroblasts, ERK1/2 activation
was blocked by U0126 and p38 activity by SB203580 (Suppl. Fig. 2).
Both inhibitors feature high speciﬁcity; for such, U0126 does not inhibit
other kinases including c-Abl, Raf, MEKK, ERK, JNK, MKK3/4/6, CDK2/4
and PKC (according to the manufacturer's description). Under control
conditions (pH 7.4) TNF-α and MCP-1 mRNA were sensitive to ERK1/2,
but not to p38 activity (Fig. 4A, C). When ERK1/2 signaling was blocked,
expression was reduced three or twofold, respectively. COX-2 mRNA
was independent of both MAP kinases (Fig. 4E). The basal expression of
iNOS at pH 7.4 did not change signiﬁcantly in the presence of U0126
and SB203580 (Fig. 4G).
Under acidotic conditions the expression of TNF-α, COX-2 and iNOS
was increased after 3 h (Fig. 1). However, this increase was unaffected
by blocking ERK1/2 activity by U0126 (Fig. 4B, F, H), indicating that
the increased expression was not the result of ERK1/2 activation.
However, when p38 activity was inhibited by SB203580, acidosis-
induced expression of iNOS and COX-2 was diminished (Fig. 4F, H).
Therefore, acidosis-increased expression of these genes is at least
partially the result of a p38 activation. Acidosis-induced TNF-α
expressionwas almost unaffected by the p38 status (Fig. 4B). The expres-
sion of MCP-1 at pH 6.6 was only slightly reduced when ERK1/2 or p38
was inhibited (Fig. 4D). However,whenbothwere blocked simultaneous-
ly, theMCP-1mRNA level was halved (ΔΔCq=−1.0± 0.4, n= 27, N=
9, p= 0.02; data not shown). Hence, acidosis led to a reduced expression
of MCP-1 that is counteracted by the activation of ERK1/2 and p38 after
3 h at pH 6.6. Since after 6 h or 24 hMAP kinase activation is diminished
(Fig. 3B), the beforehandmasked effect of acidosis onMCP-1 expression
becomes apparent again.
3.4. Pathways involved in acidosis-induced signaling
Extracellular acidosis led to a signiﬁcant reduction of intracellular pH
(pHi) from 6.84± 0.01 (n=98, N=8) at pHe 7.4 to 6.5± 0.02 (n=36,
N= 4, p= 1 × 10−19) at pHe 6.6. Whether extracellular or intracellular
acidiﬁcation is the prerequisite for MAPK activation was studied by sole
intracellular acidiﬁcation (at pHe 7.4). Therefore NRKF cells were chal-
lenged with 40 mM of propionic acid in the presence of a Na+/H+ ex-
change inhibitor (10 μM of EIPA/amiloride) and a blocker of anion
transport (200 μM of DIDS) to suppress cellular pHi regulation. This
treatment reduced pHi to 6.65 ± 0.02 (Fig. 5A) but did not activate ei-
ther ERK1/2 or p38. It rather seemed to attenuate phosphorylation,
especially of ERK1/2 (Fig. 5B). Therefore it seems that intracellular
acidiﬁcation is not necessary and furthermore not sufﬁcient to induce
MAPK activation. However, since the inhibitors used might exert
additional regulatory effects on other signaling pathways, we cannot
completely exclude the possibility that intracellular acidosis contributes
to the activation of MAPK. Since extracellular acidosis emerged as crucial
step in MAPK activation in ﬁbroblasts, the role of G protein-coupled pH
sensors was analyzed. NRKF cells express GPR4, GPR68 and GPR132
mRNA (Fig. 6A). G protein-coupled receptors (GPCRs) lead to the
activation of phospholipase C/Ca2+ signaling and/or adenylyl cyclase/
cAMP signaling pathway [43]. However, acidosis neither led to an
elevated cAMP production nor to an increase in free calcium (Fig. 6B,
C). On the contrary, both parameters decreased signiﬁcantly during
acidosis. In addition, micromolar concentrations of Cu2+ that are
known to block GPR68/OGR1 activation by coordinating the histidines
at the extracellular surface needed for pH sensing [44], did not prevent
acidosis-induced MAPK phosphorylation (Suppl. Table 1). Hence, an
Fig. 1. Time course of acidosis-inducedmRNA expression of (A) TNF-α, (B) MCP-1, (C) COX-2 and (D) iNOS. Fold regulation andΔΔCq values of pH 6.6 compared to pH 7.4 at 3 h, 6 h and
24 h are shown, n = 21–66, N = 7–19. (*) p b 0.05.
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signaling in ﬁbroblasts revealed an inhibitory action of this pathway
on acidosis-induced activation of MAPK. The cAMP antagonist RP-
adenosine-3′,5′-cyclic monophosphorothioate (Rp-cAMPS), thatFig. 2. Relative acidosis-induced expression of (A) total TNF-α protein, n= 6–12; (B) total COX
cells. Values at pH 6.6 were compared to the respective values at pH 7.4 at the indicated time
shown. (*) p b 0.05.prevents cAMP-mediated signaling, increased MAPK phosphorylation
at pH 7.4 (ERK1/2: +56 ± 21%, p = 0.05 and p38: +60 ± 5%, p =
0.001; n/N = 4–5) and by this decreased acidosis-induced ERK1/2
and p38 phosphorylation signiﬁcantly (Fig. 7A). Therefore cAMP--2 protein, n = 4–5; and (C) formation of nitrate and nitrite, n = 12–15, N= 4–5 in NRKF
points, additionally representative Western blots for TNF-α and COX-2 total protein are
Fig. 3. Impact of acidosis on the activity of ERK1/2 and p38. (A) RepresentativeWestern blots of total andphosphorylated protein after an incubation period of 3 h at pH7.4 or pH6.6. (B) Semi-
quantitative analysis of Western blots showing activation of ERK1/2 and p38 after the stated incubation periods with pH 6.6 (compared to pH 7.4), n/N = 4–8. (*) p b 0.05 vs. pH 7.4.
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By acidosis-induced reduction of intracellular cAMP this inhibitory
pathway is blocked and MAPK activity increases. Potential other
signaling pathways involved in MAPK signaling were investigated
pharmacologically. Acidosis-induced phosphorylation of MAPK was
independent of EGFR, PKC, Src kinase family, Pyk2, FAK and PI3-kinase
(Suppl. Table 1). Since results in tumor cells showed that reactive
oxygen species play a role in acidosis-induced activation of ERK1/2
and p38 [36] we investigated whether NRKF cells display a similar link
between ROS and MAPK. Therefore ROS level was either increased by
adding H2O2 or reduced by application of the scavenger Tiron. Incubating
the cells with 0.1 mM of H2O2 at pH 7.4 increased the phosphorylation of
ERK1/2 slightly (+79 ± 36%, n/N = 4, p = 0.03) but not of p38 (+6 ±
21%, n/N = 5, p = 0.29). Scavenging ROS with Tiron inﬂuenced phos-
phorylation of MAPK neither under control (pH 7.4) nor under acidic
(pH 6.6) conditions (Suppl. Table 1). In addition, acidosis did not lead to
an increased production of ROS in NRKF cells (+33 ± 16%, n = 15,Fig. 4. Dependence of TNF-α, iNOS, COX-2 and MCP-1 mRNA levels on ERK1/2 and p38 signa
SB203580 (10 μM) on basal mRNA expression at pH 7.4. Fold regulation and ΔΔCq comparing
of 3 h are shown, n= 30–36, N=10–12. (B, D, F, H) Effect of 10 μMof U0126 or 10 μMof SB203
ΔΔCq comparing pH 7.4 with pH 6.6 (vehicle = DMSO) and pH 7.4 plus inhibitor with pH 6.6N= 5, p = 0.09) in contrast to cancer cells [36]. Therefore, ROS are not
involved in acidosis-induced signaling. Since the phosphorylation state
of MAPK is controlled by a concerted interplay between kinases and
phosphatases [45], the role of phosphatases in an acidic environment
was analyzed, too. Under conditions of inhibited serine/threonine protein
phosphatase (PSP) activity in the presence of okadaic acid, acidosis-
induced activation of ERK1/2 and p38 was impeded (Fig. 7B). Inhibition
of phosphatase activity elevated the amount of phosphorylated MAPK
under control conditions (pH 7.4) as expected (ERK1/2: +506 ± 233%,
n/N = 9, p = 0.04; p38: +212 ± 95%, n/N = 9, p = 0.03). However at
pH 6.6 the acidosis-induced increase in MAPK phosphorylation was
reduced, which was not the case when protein tyrosine phosphatase
(PTP) activity was blocked (Suppl. Table 1). Therefore the actions of
PSPs, but not PTPs are part of the signaling cascade leading to a reduced
dephosphorylation and hence elevated activity of MAPK in an acidic
microenvironment. In summary, proton-sensing GPCRs are not crucial
for the transduction of the signal extracellular acidosis into the cell andling pathways. (A, C, E, G) Effect of MEK1/2 inhibitor U0126 (10 μM) and p38 inhibitor
pH 7.4 (vehicle = DMSO) with pH 7.4 plus respective inhibitor after an incubation period
580 on acidosis-induced expression of TNF-α, iNOS, COX-2 andMCP-1. Fold regulation and
plus respective inhibitor are shown, n = 33–36, N = 11–12. (*) p b 0.05.
Fig. 5. Impact on intracellular acidosis on signaling. (A) Intracellular pH (pHi) is reduced when extracellular pH is lowered or when extracellular pH is constant at pH 7.4 and cells are
challengedwith 40mMofpropionic acid, 10 μMof EIPA (Na+/H+ antiporter inhibitor) and200 μMofDIDS (4,4′-diisothiocyanatostilbene-2,2′-disulfonic acid; anion transporter inhibitor),
n= 36–56, N= 4. (B) Effect of extracellular and intracellular acidosis on ERK1/2 and p38 phosphorylations, representativeWestern blots and semi-quantitative analysis ofWestern blots
(compared to pH 7.4), n = 3–7, N = 3–4. (*) p b 0.05.
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required.
4. Discussion
4.1. Activation of inﬂammatory programs by acidosis
The results of the present study clearly reveal that extracellular
acidosis, which results e.g. from an insufﬁcient oxygen supply followed
by a switch to glycolytic metabolism under different pathophysiological
conditions, leads to pronounced effects on the transcriptional program of
ﬁbroblasts. The expression of TNF-αwas increased after 3 h at pH 6.6, butFig. 6. Involvement of GPCRs in acidosis-induced signaling. (A) Expression of statedGPCRs inNR
no reverse transcriptase added to reverse transcription. (B) Effect of 15min acidosis on cellular
change in cellular free calcium content during incubation with pH 6.6 monitored with Fura-2,decreased below control level after 24 h of acidosis. Since elevated gene
and protein expression were ceased already within 6 h of acidosis,
fostering the action of TNF-α seems to be important under conditions
of alternating pH, which is often the case in pathological micromilieus.
Long-lasting acidosis seems to reduce the inﬂammatory response and
may therefore be immunosuppressive. TNF-α expressionwas increased
by extracellular acidosis independently of p38 or ERK1/2. However,
basal expression of TNF-α under control condition (pH 7.4) depended
markedly on ERK1/2 signaling. The level of MCP-1 mRNA was reduced
by acidosis, however this effect was not seen until 6 to 24 h of acidosis,
because it is compensated after 3 h by the activation of ERK1/2 and p38
that increases MCP-1 mRNA level. Thus, acidosis exerts an additionalKF cells, positive control (C) is amix of the rat lung, spleen and thymus.− negative control,
cAMP content, 3 μMof Forskolinwas used as positive control, n= 10; N= 5. (C) Dynamic
n = 12, N = 3.
Fig. 7. Changes in the acidosis-induced phosphorylation of ERK1/2 and p38 in dependency of (A) cAMP antagonist Rp-cAMPS (50 μM) and (B) Ser/Thr phosphatase inhibitor okadaic acid (OA;
100 nM). Semi-quantitative analysis (pH 7.4 compared with pH 6.6 with or without the stated inhibitors) and representativeWestern blots are shown, n/N= 4–5. (*) p b 0.05 versus vehicle.
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expression of COX-2 and iNOS was augmented at pH 6.6 for 3 h to 6 h,
an effect which was dependent on the activation of the p38 MAP kinase.
This increase led to an elevated level of COX-2 and iNOSprotein (the latter
as indicated by an increased nitrate and nitrite production). Under
pathological conditions this contributes to exacerbated inﬂammation by
elevated production of reactive nitrogen species and prostaglandins,
respectively. COX-2 and iNOS activity or expression is induced by
extracellular acidosis in different cell types like endothelial cells, small
intestinal mucosa or osteoblasts [2,46,47]. Besides, several stimuli
have been described to induce iNOS or COX-2 in ﬁbroblasts in a p38-
dependent manner [48,49]. However, the present study is the ﬁrst in
which the role of extracellular acidosis for iNOS and COX-2 expression
has been described in ﬁbroblasts. It is known that p38 can stabilize
inﬂammatory response protein mRNA and promote their translation
through adenylate–uridylate-rich elements in the 3′ untranslated
region of the mRNAs [9]. This stabilization has been shown in detail
for COX-2 [50], furthermore it is known that iNOS is p38-dependent [8,
51]. A similar mechanism in ﬁbroblasts therefore seems likely. Interest-
ingly, the stimulation of inﬂammation by acidosis has been shown for
other cell types such as renal, endothelial and immune cells before [2,5,
6,52] pointing out to a general phenomenon.
4.2. Acidosis-induced signaling
When extracellular pH is lowered, intracellular pH decreases
substantially without induction of apoptosis or necrosis under our
experimental settings (Suppl. Fig. 3). Cellular signaling was analyzed
in respect to MAP kinase activity, since MAPK are known to be involved
in the response to different stress stimuli. Both ERK1/2 and p38 were
activated by extracellular acidosis, but not by intracellular acidiﬁcation
alone. Therefore it seems likely that extracellular pH directly inﬂuences
the MAPK signaling cascade. Besides several other pathways (Suppl.
Table 1), we could exclude a critical role of GPCR or ROS signaling for
acidosis-induced MAPK activation. Antagonizing the cAMP pathway
revealed an inhibitory action of the cAMP pathway on ERK1/2 and p38signaling in ﬁbroblasts. Since acidosis decreased intracellular cAMP
levels, which can be explained by the pH sensitivity of membrane-
associated adenylyl cyclases, we suggest that acidosis leads to a plasma
membrane-adjacent suppression of cAMP formation and signaling, that
has to be investigated in more detail in future studies. The impact of
cAMP-dependent protein kinase pathways on MAPK activity can be
both stimulating and inhibiting (for overview see [53]) andmay involve
PKAor EPAC [54]. Besides cAMPsignaling, the increase in phosphorylated
ERK1/2 and p38was linked to a decrease in Ser/Thr-phosphatase activity
at pH 6.6, but independent of the action of Tyr-phosphatases. It is
conceivable, that the cAMP pathway acts either in parallel to the
phosphatase pathway or in series. It had been shown on the one
hand, that the cAMP/PKA pathway stimulates the activity of okadaic
acid sensitive phosphatases [55–57]. Additionally, PKA can regulate the
activity of various protein phosphatase inhibitory proteins [58–60] and
by this can activate PSPs. On the other hand, there are also scenarios of a
parallel action of the cAMP/PKA pathway and phosphatases, in which
MAPK phosphorylation is regulated independently of each other [61,
62]. For such, PKA can block MAPK signaling for instance through
RAF-1 [53]. In conclusion, acidosis increases phosphorylation of MAPK
by abrogating inhibitory signals of the cAMP/PKA pathway and by
reducing dephosphorylation through PSPs. We propose a model were
an acidic microenvironment inﬂuences COX-2, iNOS and MCP-1 expres-
sion via cAMP- and PSP-dependent MAPK activation. The pathway
involved in acidosis-induced upregulation of TNF-α is different and
needs to be determined in more detail in future studies.
4.3. MAP kinase activation under pathological conditions
Since ﬁbroblasts are part of almost every tissue, these cells are
exposed to the metabolic microenvironment induced under various
pathological situations (e.g., inﬂammation, ischemia, tumor). Although
MAPK activation is described for different cell types in inﬂammation,
in ischemia and in solid tumors [10,11,28,63–65], until now, there was
not much data on their role in residing ﬁbroblasts. Yoo et al. showed
that in colonic myoﬁbroblasts an increase in ERK1/2 phosphorylation
306 A. Riemann et al. / Biochimica et Biophysica Acta 1853 (2015) 299–307resulted in enhanced COX-2 expression [66] which might participate
in the pathomechanism of inﬂammatory bowel disease and colitis-
associated cancer. Thus, although acidosis-induced MAPK activation in
ﬁbroblasts has not been described yet, it is already shown for other
stimuli of the pathological microenvironment. Recent studies focus
more and more on the role of cancer associated ﬁbroblasts (CAFs) that
are exposed to the tumor microenvironment and play an important
role in tumor initiation and progression [67]. In the work of Navab
et al. the gene expression signature of CAFs was analyzed and they
found a prominent involvement of MAPK signaling pathways [68].
From the present results it becomes obvious that ﬁbroblasts exposed
to an acidic microenvironment may modulate the immune response
in cancer which in turn may affect the malignant tumor progression.
5. Conclusion
Metabolic acidosis is an important parameter of the local environment
found in different pathological situations like inﬂammation, ischemia and
tumors. Our data show that it affects theﬁbroblasts located in suchmicro-
environments in concern of their signaling and gene expression (Fig. 8).
Short-term acidosis may result in an aggravation of the pathological
situation by activating theMAP kinases ERK1/2 and p38 that are involved
in stress response and a multitude of cellular processes like proliferation,
cell survival and the production of inﬂammatory mediators. The expres-
sion of inﬂammatorymediators TNF-α, iNOS and COX-2was signiﬁcantly
elevated and leads to the generation of a parainﬂammatory situation that
can result in tissue remodeling and ﬁbrosis, and in the attenuation of
tumor progression. On the other hand, long-term or chronic acidosis
seems to foster anti-inﬂammatory processes by lowering MCP-1, TNF-α
and COX-2 expression. This may reduce the recruitment of immune
cells to the inﬂammatory site and protect the tissue, but it will also be
permissive for tumor growth.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2014.11.022.
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expression of inﬂammatory mediators. Pathological conditions with metabolic acidosis lead
to an enhanced expression of COX-2 and iNOS in ﬁbroblasts that depends on a cAMP-PSP-
mediated MAP kinase activation and may result in an aggravation of inﬂammation and
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